Cancer BiologybioRxiv
An RNA-binding switch drives ribosome biogenesis and tumorigenesis downstream of RAS oncogene
M. S. Azman, M. Dodel, F. Capraro…·F. K. Mardakheh
This study identifies Nucleolin as a key mediator of RAS-driven ribosome biogenesis and tumorigenesis through enhanced RNA-binding activity.
DOI 10.15252/embj.2022110902